The Union health ministry aims to restrict advertising of prescription drugs by retailers and distributors, requiring prior government approval. This measure is in response to concerns about unauthorized promotion and inappropriate self-medication. A new sub-rule is proposed to ensure compliance across the pharmaceutical supply chain. Stakeholders are invited to provide feedback on this draft notification within 30 days.